SCI Pharmtech Inc Working Capital to Net Assets Ratio
SCI Pharmtech Inc working capital to net assets ratio. SCI Pharmtech Inc (4119) has a Working Capital to Net Assets ratio of 4.0% as of June 2026. Working capital of NT$214.49 Million (current assets of NT$1.06 Billion minus current liabilities of NT$848.64 Million) is measured against net assets of NT$5.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SCI Pharmtech Inc (2009–2025)
Working capital to net assets ratio of SCI Pharmtech Inc from 2009 to 2025. This chart shows how SCI Pharmtech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the ratio stands at 4.0%, reflecting working capital of NT$214.49 Million against net assets of NT$5.31 Billion TWD. Explore SCI Pharmtech Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
SCI Pharmtech Inc Working Capital to Net Assets Ratio by Year (2009–2025)
SCI Pharmtech Inc working capital to net assets ratio by year from 2009 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SCI Pharmtech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SCI Pharmtech Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.0% | NT$54.05 Million | NT$5.39 Billion | NT$1.09 Billion | NT$1.04 Billion | ▼ -10.8 pp |
| 2024 | 11.8% | NT$646.01 Million | NT$5.48 Billion | NT$1.66 Billion | NT$1.01 Billion | ▼ -15.3 pp |
| 2023 | 27.1% | NT$1.38 Billion | NT$5.10 Billion | NT$1.95 Billion | NT$569.89 Million | ▲ +19.6 pp |
| 2022 | 7.5% | NT$272.08 Million | NT$3.63 Billion | NT$1.04 Billion | NT$770.32 Million | ▼ -12.1 pp |
| 2021 | 19.6% | NT$649.37 Million | NT$3.32 Billion | NT$1.40 Billion | NT$747.94 Million | ▼ -4.4 pp |
| 2020 | 24.0% | NT$796.60 Million | NT$3.32 Billion | NT$1.92 Billion | NT$1.12 Billion | ▼ -14.9 pp |
| 2019 | 38.9% | NT$1.35 Billion | NT$3.47 Billion | NT$1.94 Billion | NT$584.26 Million | ▲ +3.1 pp |
| 2018 | 35.8% | NT$1.15 Billion | NT$3.21 Billion | NT$1.71 Billion | NT$556.71 Million | ▲ +1.8 pp |
| 2017 | 34.0% | NT$995.81 Million | NT$2.93 Billion | NT$1.34 Billion | NT$342.97 Million | ▼ -4.0 pp |
| 2016 | 38.0% | NT$1.17 Billion | NT$3.07 Billion | NT$1.62 Billion | NT$455.40 Million | ▲ +6.8 pp |
| 2015 | 31.3% | NT$863.33 Million | NT$2.76 Billion | NT$1.54 Billion | NT$672.91 Million | ▼ -10.7 pp |
| 2014 | 41.9% | NT$933.33 Million | NT$2.23 Billion | NT$1.33 Billion | NT$396.56 Million | ▼ -6.2 pp |
| 2013 | 48.1% | NT$995.58 Million | NT$2.07 Billion | NT$1.39 Billion | NT$391.43 Million | ▲ +26.9 pp |
| 2012 | 21.2% | NT$267.82 Million | NT$1.26 Billion | NT$571.73 Million | NT$303.92 Million | ▲ +2.7 pp |
| 2011 | 18.6% | NT$209.90 Million | NT$1.13 Billion | NT$582.17 Million | NT$372.27 Million | ▲ +3.4 pp |
| 2010 | 15.1% | NT$171.02 Million | NT$1.13 Billion | NT$536.10 Million | NT$365.08 Million | ▼ -12.5 pp |
| 2009 | 27.6% | NT$286.32 Million | NT$1.04 Billion | NT$495.02 Million | NT$208.71 Million | — |